“Drug Supply Chain Security: What You Need to Know Today & How to Be Prepared For The Future”
HealthTrust presents…”Drug Supply Chain Security: What You Need to Know Today & How to Be Prepared For The Future”
The Drug Supply Chain Security Act (DSCSA) is an FDA regulation passed in 2013 and is designed to act as a shield to protect patients from counterfeit and illegitimate drug products. DSCSA’s implementation is a stepwise program that will lead to a fully interoperable drug supply chain in 2023. This presentation provides an overview of current regulatory requirements and the impact of future changes to the drug supply chain that will affect clinical and revenue cycle operations. Attendees of this session will gain an in-depth understanding of how product identification (labeling) and data interoperability innovations will be utilized to not only secure the drug supply chain but also act as a gateway to more efficient operations.
Learning Objectives for pharmacists and supply chain professionals | At the end of this session, participants should be able to:
- State the current and future requirements for pharmacy under the Drug Supply Chain Security Act (DSCSA)
- Describe current and future pharmaceutical labeling evolution and supply chain innovations and challenges
- Recall current enforcement initiatives, risks and impact of noncompliance.
Learning Objectives for pharmacist technicians | At the end of this session, participants should be able to:
- Recall the evolving timeline and impact of DSCSA in pharmacy
- Identify new opportunities for supply chain transparency beyond simple compliance
Dwight deVera | Founder & CEO | The Forerunner Group | RXTransparent
Target Audience: Pharmacists, pharmacy technicians and supply chain professionals
Continuing Education Information: 1.0 contact hours approved for Pharmacists and Pharmacy Techs. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-19-081-L04-P and 0863-9999-19-081-L04-T. The activity is pending 1 hour (.1 CEUs) of continuing education credit to pharmacists and pharmacist technicians who attend the webinar and complete the online evaluation. AHRMM will offer 1.0 CPEs for those who attended the entire webinar.
Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the webinar for 40 minutes or longer in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
Effective June 1, 2019: Belmont College of Pharmacy will no longer issue paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net.
A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at email@example.com. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.